Lymphocyte imbalance in vitiligo patients indicated by elevated CD4+/CD8+ T-cell ratio

Wiener Medizinische Wochenschrift

Volumn 159, Issue 13-14, 2009, Pages 337-341

  Pichler, Robert ^a   Sfetsos, Konstantin ^a   Badics, Birgit ^a   Gutenbrunner, Sabrina ^a   Berg, Jörg ^a   Auböck, Josef ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Autoimmunity; Lymphocyte imbalance; Proinflammatory cytokines; Vitiligo

Indexed keywords

INTERLEUKIN 6; PROTEIN STNF R 1; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD4 CD8 RATIO; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MELANOCYTE; NATURAL KILLER CELL; REGRESSION ANALYSIS; T LYMPHOCYTE; VITILIGO;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CD4-CD8 RATIO; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REFERENCE VALUES; THYROIDITIS, AUTOIMMUNE; VITILIGO;

EID: 68849101888     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-009-0699-z     Document Type: Article

References (23)

1. T Passeron JP Ortonne 2005 Physiopathology and genetics of vitiligo J Autoimmun 25 63 66
2. K Ongenae N van Geel JM Naeyaert 2003 Evidence for an autoimmune pathogenesis of vitiligo Pigment Cell Res 16 90 100
3. R van den Wijngaard A Wankowicz-Kalinska S Pals J Weening P Das 2001 Autoimmune melanocyte destruction in vitiligo Lab Invest 81 1061 1067
4. A Alkahateeb PR Fain A Thody DC Bennett RA Spritz 2003 Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families Pigment Cell Res 16 208 214
5. R Pichler K Sfetsos J Auböck B Badics S Gutenbrunner J Berg 2005 Cytomegalovirus infection in central european vitiligo patients? Autoimmunity 38 121 122
6. R Pichler K Sfetsos B Badics S Gutenbrunner J Auböck 2006 Vitiligo patients present lower plasma levels of alpha-melanotropin immunoreactivities Neuropeptides 40 177 183
7. D Sinclair 2006 Clinical and laboratory aspects of thyroid antibodies Ann Clin Biochem 43 173 183
8. P Fraunberger M Pfeiffer P Cremer E Holler D Nagel I Dehart M Thein AK Walli D Seidel 1998 Validation of an automated enzyme immunoassay for interleukin-6 for routine clinical use Clin Chem Lab Med 36 797 801
9. P Santamaria 2001 Effector lymphocytes in autoimmunity Curr Opin Immunol 13 663 669
10. T Dorner 2006 Crossroads of B cell activation in autoimmunity: rationale of targeting B cells J Rheumatol Suppl 77 3 11
11. J Trcka Y Moroi RA Clynes SM Goldberg A Bergtold MA Perales M Ma CR Ferrone MC Carroll JV Ravetch AN Houghton 2002 Redundant and alternative roles for activating Fc receptors and complement in antibody-dependent model of autoimmune vitiligo Immunity 16 861 868
12. A Wańkowicz-Kalińska RM van den Wijngaard BJ Tigges W Westerhof GS Ogg V Cerundolo WJ Storkus PK Das 2003 Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo Lab Invest 83 683 695
13. S Moretti A Spallanzani L Amato G Hautmann I Gallerani M Fabiani P Fabbri 2002 New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions Pigment Cell Res 15 87 92
14. R Pichler W Maschek M Hatzl-Griesenhofer H Huber C Crespillo-Gomez J Berg 2003 Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' disease Horm Metab Res 35 427 433
15. PY Basak AK Adiloglu AM Ceyhan T Tas VB Akkaya 2009 The role of helper and regulatory T cells in the pathogenesis of vitiligo J Am Acad Dermatol 60 256 260
16. J Morales-Montor 2005 The role of the pleiotropic cytokine interleukin-6 (IL-6) during disease Mod Asp Immunobiol 16 21 26
17. N Mozzanica ML Villa S Foppa G Vignati A Cattaneo R Diotti AF Finzi 1992 Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo J Am Acad Dermatol 26 693 700
18. RM Halder CS Walters BA Johnson SG Chakrabarti JA Kenney 1986 Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study J Am Acad Dermatol 14 733 737
19. N Mozzanica U Frigerio AF Finzi A Cattaneo M Negri F Scaglione F Fraschini S Foppa 1990 T cell subpopulations in vitiligo: a chronobiologic study J Am Acad Dermatol 22 223 230
20. K Gunduz G Ozturk E Terzioglu F Sebik 2004 T cell subpopulations and IL-2R in vitiligo J Dermatol 31 94 97
21. JW Yoon HS Jun 2005 Autoimmune destruction of pancreatic beta cells Am J Ther 12 580 591
22. F Castellino RN Germain 2006 Cooperation between CD4+ and CD8+ T cells: when, where and how Annu Rev Immunol 24 519 540
23. U Walter P Santamaria 2005 CD8+ T cells in autoimmunity Curr Opin Immunol 17 624 631